Article Details
Retrieved on: 2020-12-02 15:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
FerGene Inc. today announced new <b>data analyses</b> results from the landmark Phase 3 clinical trial evaluating nadofaragene firadenovec (rAd-IFN/Syn3) ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here